JENNIFER ANDERSON: Open Payments
NPI 1730665084 · CHELMSFORD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,524 in 108 payments from 25 companies in 2025. Trend: 2023 $3,323 · 2024 $2,178 · 2025 $2,524
Food & beverage: $2,485Education: $39
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $560 |
| AstraZeneca Pharmaceuticals LP | 15 | $441 |
| PFIZER INC. | 18 | $312 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $262 |
| Vanda Pharmaceuticals Inc. | 11 | $153 |
| Novo Nordisk Inc | 6 | $149 |
| Otsuka America Pharmaceutical, Inc. | 4 | $77 |
| Astellas Pharma US Inc | 3 | $67 |
| GlaxoSmithKline, LLC. | 3 | $59 |
| Inspire Medical Systems, Inc. | 2 | $51 |
Products named: VRAYLAR, Kerendia, FANAPT, WAINUA, FARXIGA, ELIQUIS, AIRSUPRA, REXULTI.
Industry payments across MA — which companies pay providers there.
